Table 4.
Final models for MH isolation outcomes at 3 weeks.
Outcome | Variable | Value | OR | 95% CI | p-value |
---|---|---|---|---|---|
MH isolation | TxGroup | META | 1.41 | 0.90–2.22 | 0.13 |
NO META | Ref | Ref | Ref | ||
MDR MH isolation | TxGroup | META | 13.08 | 5.54–30.88 | <0.0001 |
NO META | Ref | Ref | Ref | ||
BRD Treatment x FeverAR | Interaction | – | – | 0.02 | |
N x N | Ref | Ref | Refab | ||
Y x Y | 9.70 | 1.63–57.78 | 0.061ac | ||
N x Y | 0.18 | 0.05–0.65 | 0.009b | ||
Y x N | 3.83 | 1.39–10.58 | 0.01c | ||
Isolation of MH containing ICE | TxGroup | META | 3.43 | 2.08–5.66 | <0.0001 |
NO META | Ref | Ref | Ref |
BRD treatment (Yes or No) indicates whether an animal received antimicrobials for BRD treatment before 3 week sampling. Weight at arrival input is difference from median weight (232 kg). TxGroup, treatment group; BRD, bovine respiratory disease; MDR, multidrug resistant; MH, Mannheimia haemolytica; Ref, reference; OR, Odds Ratio; CI, confidence interval; META, tulathromycin metaphylaxis; NO META, no tulathromycin metaphylaxis. Values in the same column with different superscripts indicate statistically significant difference (Pairwise Comparison of LS Means Differences, p < 0.05).